Search

Simple Summary: Tumor tissues sampled from patients contain prognostic and predictive information beyond what is currently being used in clinical practice. Large-scale digitization enables new ways of exploiting this information. The most promising analysis pipelines include deep learning/artificial intelligence (AI). However, to ensure success, AI often requires a time-consuming curation of data. In our approach, we repurposed AI pipelines and training data for cell segmentation and classification to identify tissue-infiltrating lymphocytes (TILs) in lung cancer tissue. We showed that our approach is able to identify TILs and provide prognostic information in an unseen dataset from lung cancer patients. Our methods can be adapted in myriad ways and may help pave the way for the large-scale deployment of digital pathology. Increased levels of tumor-infiltrating lymphocytes (TILs) indicate favorable outcomes in many types of cancer. The manual quantification of immune cells is inaccurate and time-consuming for pathologists. Our aim is to leverage a computational solution to automatically quantify TILs in standard diagnostic hematoxylin and eosin-stained sections (H&E slides) from lung cancer patients. Our approach is to transfer an open-source machine learning method for the segmentation and classification of nuclei in H&E slides trained on public data to TIL quantification without manual labeling of the data. Our results show that the resulting TIL quantification correlates to the patient prognosis and compares favorably to the current state-of-the-art method for immune cell detection in non-small cell lung cancer (current standard CD8 cells in DAB-stained TMAs HR 0.34, 95% CI 0.17–0.68 vs. TILs in HE WSIs: HoVer-Net PanNuke Aug Model HR 0.30, 95% CI 0.15–0.60 and HoVer-Net MoNuSAC Aug model HR 0.27, 95% CI 0.14–0.53). Our approach bridges the gap between machine learning research, translational clinical research and clinical implementation. However, further validation is warranted before implementation in a clinical setting. [ABSTRACT FROM AUTHOR]

We have attempted to reproduce the results in Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs, published in JAMA 2016; 316(22), using publicly available data sets. We re-implemented the main method in the original study since the source code is not available. The original study used non-public fundus images from EyePACS and three hospitals in India for training. We used a different EyePACS data set from Kaggle. The original study used the benchmark data set Messidor-2 to evaluate the algorithm's performance. We used another distribution of the Messidor-2 data set, since the original data set is no longer available. In the original study, ophthalmologists re-graded all images for diabetic retinopathy, macular edema, and image gradability. We have one diabetic retinopathy grade per image for our data sets, and we assessed image gradability ourselves. We were not able to reproduce the original study's results with publicly available data. Our algorithm's area under the receiver operating characteristic curve (AUC) of 0.951 (95% CI, 0.947-0.956) on the Kaggle EyePACS test set and 0.853 (95% CI, 0.835-0.871) on Messidor-2 did not come close to the reported AUC of 0.99 on both test sets in the original study. This may be caused by the use of a single grade per image, or different data. This study shows the challenges of reproducing deep learning method results, and the need for more replication and reproduction studies to validate deep learning methods, especially for medical image analysis. Our source code and instructions are available at: . [ABSTRACT FROM AUTHOR]

Skin cancer is one of the most common types of cancer. Skin cancers are classified as nonmelanoma and melanoma, with the first type being the most frequent and the second type being the most deadly. The key to effective treatment of skin cancer is early detection. With the recent increase of computational power, the number of algorithms to detect and classify skin lesions has increased. The overall verdict on systems based on clinical and dermoscopic images captured with conventional RGB (red, green, and blue) cameras is that they do not outperform dermatologists. Computer‐based systems based on conventional RGB images seem to have reached an upper limit in their performance, while emerging technologies such as hyperspectral and multispectral imaging might possibly improve the results. These types of images can explore spectral regions beyond the human eye capabilities. Feature selection and dimensionality reduction are crucial parts of extracting salient information from this type of data. It is necessary to extend current classification methodologies to use all of the spatiospectral information, and deep learning models should be explored since they are capable of learning robust feature detectors from data. There is a lack of large, high‐quality datasets of hyperspectral skin lesion images, and there is a need for tools that can aid with monitoring the evolution of skin lesions over time. To understand the rich information contained in hyperspectral images, further research using data science and statistical methodologies, such as functional data analysis, scale‐space theory, machine learning, and so on, are essential. This article is categorized under:Applications of Computational Statistics > Health and Medical Data/Informatics [ABSTRACT FROM AUTHOR]